FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharma Carbidopa and Levodopa Tablets 25 Recall

Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Feb 8, 2017
Recall ID
D-0455-2017
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Sun Pharma Carbidopa and Levodopa Tablets 25 starting Jan 12, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0455-2017 on Feb 8, 2017. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.

Lot numbers, UPCs & expiration codes

a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0455-2017
Classification
Class II
Status
Terminated
Recall initiated
Jan 12, 2017
FDA report date
Feb 8, 2017
Quantity
8,537 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0455-2017, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
76230
Address
270 Prospect Plains Rd
Code information
a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17
Postal code
08512-3605
Report date
Feb 8, 2017
Product type
Drugs
Recall number
D-0455-2017
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
8,537 bottles
Termination date
Jun 29, 2018
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.
Distribution pattern
Nationwide
Recall initiation date
Jan 12, 2017
Initial firm notification
Letter
Center classification date
Feb 2, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0455-2017, published Feb 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls